Belluscura (BELL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 10.25p
   
  • Change Today:
      0.000p
  • 52 Week High: 28.00
  • 52 Week Low: 7.25
  • Currency: UK Pounds
  • Shares Issued: 168.41m
  • Volume: 212,669
  • Market Cap: £17.26m

Belluscura Overview

Belluscura focuses on novel oxygen-based treatment platforms that can be adapted and applied in a wide range of markets beyond those traditionally applicable to a single product or product line. Its range of portable products will be lighter / more adaptable / have higher O₂ capacity than existing oxygen enrichment products. Whilst potentially useful for recovering COVID patients, it has a wide range of use for sufferers of pneumonia / COPD (i.e. asthma/ emphysema /chronic bronchitis) and other respiratory illnesses.

1 Day Chart (31-10-2024)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -2144.5% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 26.9 n/a
Pr/Book 1.3  
Latest F'cast
Revenue -41.0% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Belluscura Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 n/a (1.98) (0.04)¢ n/a n/a n/a n/a 0.0%
31-Dec-21 0.42 (5.21) (5.50)¢ n/a n/a n/a n/a 0.0%
31-Dec-22 1.40 (8.15) (5.50)¢ n/a n/a n/a n/a 0.0%
31-Dec-23 0.82 (18.52) (14.20)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Belluscura Company Announcements

Trading Update 28-Oct-2024 07:00 RNS
Half-year Report 26-Sep-2024 07:00 RNS
Holding(s) in Company 13-Sep-2024 13:37 RNS

Belluscura ShareCast News

Belluscura group revenues continue to grow YTD 28-Oct-2024 ShareCast
Belluscura shares surge on strong sales momentum... 27-Aug-2024 ShareCast
Belluscura makes 'significant progress', propose... 12-Jun-2024 ShareCast

Latest Belluscura Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Belluscura Market Data

Currency UK Pounds
Share Price 10.25p
Change Today 0.000p
% Change 0.00 %
52 Week High 28.00
52 Week Low 7.25
Volume 212,669
Shares Issued 168.41m
Market Cap £17.26m

Belluscura Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
5.02% above the market average5.02% above the market average5.02% above the market average5.02% above the market average5.02% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Price Trend
39.48% below the market average39.48% below the market average39.48% below the market average39.48% below the market average39.48% below the market average
29.73% below the sector average29.73% below the sector average29.73% below the sector average29.73% below the sector average29.73% below the sector average
Income Not Available
Growth
4.99% below the market average4.99% below the market average4.99% below the market average4.99% below the market average4.99% below the market average
11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average

Belluscura Dividends

No dividends found

Trades for 31-Oct-2024

Time Volume / Share Price
14:23 13,281 @ 10.13p
12:57 80,000 @ 10.25p
10:09 15,722 @ 10.13p
10:08 23,200 @ 10.13p
10:07 15,722 @ 10.13p

Belluscura Key Personnel

CEO Robert “Bob” Rauker
CFO Simon Neicheril

Top of Page